Universitat de Vic Report issue

Academic/Hospital Phase 2 Phase 3 Phase 4
Founded: Barcelona Spain (1599)

Organization Overview

First Clinical Trial
2005
NCT00502047
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2009

Timeline

NOW
  • Now

Alternative names

Centro de Atención Primaria El Remei, Vic, Barcelona (Spain) | Universitat de Vic- Universitat Central de Catalunya (UVic-UCC)

Active Ingredients

Drugs in Phase 4 Trials (1)

simvastatin (zocor) (1 trial)

Drugs in Phase 3 Trials (1)

plantago ovata (1 trial)

Drugs in Phase 2 Trials (4)

fluorouracil (efudex) (1 trial)

irinotecan (Camptosar) (1 trial)

leucovorin (1 trial)

panitumumab (vectibix) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Cardiovascular Diseases (Phase 3)

Colorectal Neoplasms (Phase 2)

Hypercholesterolemia (Phase 3)

Stroke (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 3
  • # of Trial APIs: 6